Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein

被引:33
作者
Raevaara, TE
Vaccaro, C
Abdel-Rahman, WM
Mocetti, E
Bala, S
Lönnqvist, KE
Kariola, R
Lynch, HT
Peltomäki, P
Nyström-Lahti, M
机构
[1] Univ Helsinki, Div Genet, Dept Biosci, FIN-00014 Helsinki, Finland
[2] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[3] Univ Helsinki, Dept Med Genet, Helsinki, Finland
[4] Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA
[5] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA
关键词
D O I
10.1016/S0016-5085(03)00905-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Hereditary nonpolyposis colorectal cancer is associated with mismatch repair deficiency. Most predisposing mutations prevent the production of functional mismatch repair protein. Thus, when the wildtype copy is also inactivated, the cell becomes mismatch repair deficient, and this leads to a high degree of microsatellite instability in tumors. However, tumors linked to nontruncating mutations may display positive or partly positive immunohistochemical staining of the mutated protein and low or atypical microsatellite instability status, which suggests impaired functional activity but not a total lack of mismatch repair. We found human mutL homology (hMLH) 1 del616, one of the most widespread recurring mutations in hereditary nonpolyposis colorectal cancer, segregating in a large hereditary nonpolyposis colorectal cancer family. Because the predicted coding change is a deletion of only :1 amino acid, the pathogenicity of the mutation was evaluated. Methods: Many analyses were performed to assess the pathogenicity of hMLH1 del616 and to study the expression and function of the mutated messenger RNA and protein. Results: Genetic and immunohistochemical evidence supported hMLH1-linked cancer predisposition in this family. Microsatellite instability varied from low to high, and the hMLH1 protein was lost in 2 tumors but was partly detectable in :1 tumor. Whereas similar optimal amounts of mutated hMLH1 del616 and wild-type hMLH:1 proteins were equally functional in an in vitro mismatch repair assay, the amount of in vivo-expressed hMLH1 del616 was much lower than the amount of wild-type protein; this suggests that the deletion imparts instability to the mutant protein. Conclusions: Our results suggest that the pathogenicity of hMLH1 del616 is not linked to nonfunctionality, but to shortage of the functional protein.
引用
收藏
页码:501 / 509
页数:9
相关论文
共 36 条
[1]  
AALTONEN LA, 1994, CANCER RES, V54, P1645
[2]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[3]  
Boland CR, 1998, CANCER RES, V58, P5248
[4]  
Curia MC, 1999, CANCER RES, V59, P3570
[5]   Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae [J].
Ellison, AR ;
Lofing, J ;
Bitter, GA .
HUMAN MOLECULAR GENETICS, 2001, 10 (18) :1889-1900
[6]   Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls [J].
Farrington, SM ;
Lin-Goerke, J ;
Ling, J ;
Wang, YT ;
Burczak, JD ;
Robbins, DJ ;
Dunlop, MG .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :749-759
[7]   The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer [J].
Guerrette, S ;
Acharya, S ;
Fishel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6336-6341
[8]   THE MOLECULAR-BASIS OF TURCOTS-SYNDROME [J].
HAMILTON, SR ;
LIU, B ;
PARSONS, RE ;
PAPADOPOULOS, N ;
JEN, J ;
POWELL, SM ;
KRUSH, AJ ;
BERK, T ;
COHEN, Z ;
TETU, B ;
BURGER, PC ;
WOOD, PA ;
TAQI, F ;
BOOKER, SV ;
PETERSEN, GM ;
OFFERHAUS, GJA ;
TERSMETTE, AC ;
GIARDIELLO, FM ;
VOGELSTEIN, B ;
KINZLER, KW .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (13) :839-847
[9]   Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients [J].
Liu, B ;
Parsons, R ;
Papadopoulos, N ;
Nicolaides, NC ;
Lynch, HT ;
Watson, P ;
Jass, JR ;
Dunlop, M ;
Wyllie, A ;
Peltomaki, P ;
delaChapelle, A ;
Hamilton, SR ;
Vogelstein, B ;
Kinzler, KW .
NATURE MEDICINE, 1996, 2 (02) :169-174
[10]  
MIYAKI M, 1995, J MOL MED-JMM, V73, P515